Futura Medical (LON:FUM) Stock Price Up 11.1% – Should You Buy?

Futura Medical plc (LON:FUM)’s share price traded up 11.1% during trading on Thursday . The company traded as high as GBX 0.40 and last traded at GBX 0.40. 8,094,989 shares were traded during mid-day trading, a decline of 5% from the average daily volume of 8,524,908 shares. The stock had previously closed at GBX 0.36.

Futura Medical Price Performance

The firm has a fifty day simple moving average of GBX 0.60 and a 200-day simple moving average of GBX 1. The firm has a market cap of £2.33 million, a P/E ratio of -0.14 and a beta of 0.02.

Futura Medical (LON:FUM) last released its quarterly earnings data on Wednesday, April 29th. The company reported GBX (2.78) EPS for the quarter. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%. The firm had revenue of GBX 170 million for the quarter. On average, equities analysts predict that Futura Medical plc will post 2.8486672 earnings per share for the current year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.